Endocervical adenocarcinoma in situ (AIS) is a precursor to invasive endocervical
adenocarcinoma. Several subtypes of AIS have been described; the most commonly …

Endocervical adenocarcinomas are rare and aggressive neoplasms. Papillary serous
endocervical adenocarcinomas are the rarest form of endocervical adenocarcinomas. This …

We describe the clinicopathologic and immunohistochemical features of the first reported
case of an ovarian low-grade serous carcinoma metastatic to the cervix mimicking a cervical …

With the introduction of the diagnostic category of endocervical adenocarcinoma in situ (AIS)
in the 2001 Bethesda System for reporting cervical cytology, the cytologist is now charged …

Misdiagnosis of endocervical adenocarcinoma (EAC) as endometrial endometrioid
carcinoma (EEC) is one of the major concerns when evaluating endometrial curettage …

Adenocarcinoma in situ (AIS) of the endocervix is typically confined to the cervix, but may be
extensive. We report 2 cases of extensive AIS—one with intraendometrial spread—that …

Background Uterine or endocervical biopsies that contain endometrioid adenocarcinoma
with widespread squamous metaplasia are usually of endometrial origin. The presence of …

Serous carcinomas most commonly arise within the uterine corpus or ovary/fallopian tube,
but there are 2 prior case reports of primary vaginal serous carcinoma. We report 2 …

A serous carcinoma and endometrial intraepithelial carcinoma were encountered in an
endometrial adenofibroma in a 61-year-old woman. The carcinoma involved the …

The presence of cytokeratins, IgA, alphafetoprotein (AFP), beta-Human Chorionic
Gonadotropin (HCG), Carcinoembryonic antigen (CEA) and Epithelial Membrane Antigen …